Optimal Differentiation of High- and Low-grade Glioma and Metastasis: a Meta-analysis of Perfusion, Diffusion, and Spectroscopy Metrics

Overview

Journal Neuroradiology

Specialties Neurology
Radiology

Date 2016 Jan 16

PMID 26767528

Citations 48

Authors

Jurgita Usinskiene

Agne Ulyte

Atle Bjornerud

Jonas Venius

Vasileios K Katsaros

Ryte Rynkeviciene

Simona Letautiene

Darius Norkus

Kestutis Suziedelis

Saulius Rocka

Andrius Usinskas

Eduardas Aleknavicius

Affiliations

Soon will be listed here.

Abstract

Introduction: To perform a meta-analysis of advanced magnetic resonance imaging (MRI) metrics, including relative cerebral blood volume (rCBV), normalized apparent diffusion coefficient (nADC), and spectroscopy ratios choline/creatine (Cho/Cr) and choline/N-acetyl aspartate (Cho/NAA), for the differentiation of high- and low-grade gliomas (HGG, LGG) and metastases (MTS).

Methods: For systematic review, 83 articles (dated 2000-2013) were selected from the NCBI database. Twenty-four, twenty-two, and eight articles were included respectively for spectroscopy, rCBV, and nADC meta-analysis. In the meta-analysis, we calculated overall means for rCBV, nADC, Cho/Cr (short TE-from 20 to 35 ms, medium-from 135 to 144 ms), and Cho/NAA for the HGG, LGG, and MTS groups. We used random effects model to obtain weighted averages and select thresholds.

Results: Overall means (with 95% CI) for rCBV, nADC, Cho/Cr (short and medium echo time, TE), and Cho/NAA were: for HGG 5.47 (4.78-6.15), 1.38 (1.16-1.60), 2.40 (1.67-3.13), 3.27 (2.78-3.77), and 4.71 (3.24-6.19); for LGG 2.00 (1.71-2.28), 1.61 (1.36-1.87), 1.46 (1.20-1.72), 1.71 (1.49-1.93), and 2.36 (1.50-3.23); for MTS 5.06 (3.85-6.27), 1.35 (1.06-1.64), 1.89 (1.72-2.06), 3.14 (1.57-4.72), (Cho/NAA was not available). LGG had significantly lower rCBV, Cho/Cr, and Cho/NAA values than HGG or MTS. No significant differences were found for nADC.

Conclusions: Best differentiation between HGG and LGG is obtained from rCBV, Cho/Cr, and Cho/NAA metrics. MTS could not be reliably distinguished from HGG by the methods investigated.

Citing Articles

The multidisciplinary management of HER2-positive breast cancer brain metastases: from new biological insights to future therapeutic options.

von Arx C, Calderaio C, Calabrese A, Marciano B, Martinelli C, Lauro V Front Oncol. 2025; 14:1447508.

PMID: 39749036 PMC: 11693720. DOI: 10.3389/fonc.2024.1447508.

Metabolic signatures derived from whole-brain MR-spectroscopy identify early tumor progression in high-grade gliomas using machine learning.

Rivera C, Bhatia S, Morell A, Daggubati L, Merenzon M, Sheriff S J Neurooncol. 2024; 170(3):579-589.

PMID: 39180640 PMC: 11614968. DOI: 10.1007/s11060-024-04812-1.

7 Tesla magnetic resonance spectroscopic imaging predicting IDH status and glioma grading.

Cadrien C, Sharma S, Lazen P, Licandro R, Furtner J, Lipka A Cancer Imaging. 2024; 24(1):67.

PMID: 38802883 PMC: 11129458. DOI: 10.1186/s40644-024-00704-9.

Peak Resembling N-acetylaspartate (NAA) on Magnetic Resonance Spectroscopy of Brain Metastases.

Ostojic J, Kozic D, Panjkovic M, Georgievski-Brkic B, Dragicevic D, Lovrenski A Medicina (Kaunas). 2024; 60(4).

PMID: 38674308 PMC: 11052432. DOI: 10.3390/medicina60040662.

Magnetic resonance-based imaging biopsy with signatures including topological Betti number features for prediction of primary brain metastatic sites.

Egashira M, Arimura H, Kobayashi K, Moriyama K, Kodama T, Tokuda T Phys Eng Sci Med. 2023; 46(4):1411-1426.

PMID: 37603131 DOI: 10.1007/s13246-023-01308-6.

References

Spampinato M, Smith J, Kwock L, Ewend M, Grimme J, Camacho D . Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors. AJR Am J Roentgenol. 2006; 188(1):204-12. DOI: 10.2214/AJR.05.1177. View

Toh C, Wei K, Chang C, Ng S, Wong H . Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction. AJNR Am J Neuroradiol. 2013; 34(6):1145-9. PMC: 7964581. DOI: 10.3174/ajnr.A3383. View

Sunwoo L, Choi S, Yoo R, Kang K, Yun T, Kim T . Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging. Neuroradiology. 2015; 57(11):1111-20. DOI: 10.1007/s00234-015-1569-6. View

Lee S, Kim J, Kim Y, Lee G, Lee E, Park I . Perfusion MR imaging in gliomas: comparison with histologic tumor grade. Korean J Radiol. 2001; 2(1):1-7. PMC: 2718089. DOI: 10.3348/kjr.2001.2.1.1. View

Kanno H, Nishihara H, Narita T, Yamaguchi S, Kobayashi H, Tanino M . Prognostic implication of histological oligodendroglial tumor component: clinicopathological analysis of 111 cases of malignant gliomas. PLoS One. 2012; 7(7):e41669. PMC: 3404002. DOI: 10.1371/journal.pone.0041669. View

Liu X, Tian W, Kolar B, Yeaney G, Qiu X, Johnson M . MR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomas. Neuro Oncol. 2011; 13(4):447-55. PMC: 3064693. DOI: 10.1093/neuonc/noq197. View

Katostaras T, Katostara N . Area of the ROC curve when one point is available. Stud Health Technol Inform. 2013; 190:219-21. View

Fellows G, Wright A, Sibtain N, Rich P, Opstad K, McIntyre D . Combined use of neuroradiology and 1H-MR spectroscopy may provide an intervention limiting diagnosis of glioblastoma multiforme. J Magn Reson Imaging. 2010; 32(5):1038-44. DOI: 10.1002/jmri.22350. View

Spampinato M, Wooten C, Dorlon M, Besenski N, Rumboldt Z . Comparison of first-pass and second-bolus dynamic susceptibility perfusion MRI in brain tumors. Neuroradiology. 2006; 48(12):867-74. DOI: 10.1007/s00234-006-0134-8. View

10.

Lev M, Ozsunar Y, Henson J, Rasheed A, Barest G, Harsh 4th G . Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. AJNR Am J Neuroradiol. 2004; 25(2):214-21. PMC: 7974605. View

11.

Chan J, Tsui E, Chau L, Chow K, Chan M, Yuen M . Discrimination of an infected brain tumor from a cerebral abscess by combined MR perfusion and diffusion imaging. Comput Med Imaging Graph. 2001; 26(1):19-23. DOI: 10.1016/s0895-6111(01)00023-4. View

12.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

13.

Thomsen H, Steffensen E, Larsson E . Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas. Acta Radiol. 2011; 53(1):95-101. DOI: 10.1258/ar.2011.110242. View

14.

Senturk S, Karli Oguz K, Cila A . Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner. Diagn Interv Radiol. 2009; 15(1):3-12. View

15.

Arevalo-Perez J, Peck K, Young R, Holodny A, Karimi S, Lyo J . Dynamic Contrast-Enhanced Perfusion MRI and Diffusion-Weighted Imaging in Grading of Gliomas. J Neuroimaging. 2015; 25(5):792-8. PMC: 5525149. DOI: 10.1111/jon.12239. View

16.

Bai X, Zhang Y, Liu Y, Han T, Liu L . Grading of supratentorial astrocytic tumors by using the difference of ADC value. Neuroradiology. 2011; 53(7):533-9. DOI: 10.1007/s00234-011-0846-2. View

17.

Shin J, Lee H, Kwun B, Kim J, Kang W, Gon Choi C . Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol. 2002; 179(3):783-9. DOI: 10.2214/ajr.179.3.1790783. View

18.

Svolos P, Tsolaki E, Kapsalaki E, Theodorou K, Fountas K, Fezoulidis I . Investigating brain tumor differentiation with diffusion and perfusion metrics at 3T MRI using pattern recognition techniques. Magn Reson Imaging. 2013; 31(9):1567-77. DOI: 10.1016/j.mri.2013.06.010. View

19.

di Costanzo A, Scarabino T, Trojsi F, Giannatempo G, Popolizio T, Catapano D . Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy. Neuroradiology. 2006; 48(9):622-31. DOI: 10.1007/s00234-006-0102-3. View

20.

Hilario A, Sepulveda J, Perez-Nunez A, Salvador E, Millan J, Hernandez-Lain A . A prognostic model based on preoperative MRI predicts overall survival in patients with diffuse gliomas. AJNR Am J Neuroradiol. 2014; 35(6):1096-102. PMC: 7965146. DOI: 10.3174/ajnr.A3837. View